Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES LUPIN ZYDUS LIFESCIENCES/
LUPIN
 
P/E (TTM) x 20.1 385.7 5.2% View Chart
P/BV x 2.4 2.7 87.7% View Chart
Dividend Yield % 0.6 0.6 111.9%  

Financials

 ZYDUS LIFESCIENCES   LUPIN
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
LUPIN
Mar-22
ZYDUS LIFESCIENCES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs6741,268 53.2%   
Low Rs331679 48.8%   
Sales per share (Unadj.) Rs149.1361.0 41.3%  
Earnings per share (Unadj.) Rs22.7-33.2 -68.4%  
Cash flow per share (Unadj.) Rs29.73.3 905.6%  
Dividends per share (Unadj.) Rs2.504.00 62.5%  
Avg Dividend yield %0.50.4 121.1%  
Book value per share (Unadj.) Rs166.1263.9 62.9%  
Shares outstanding (eoy) m1,023.74454.48 225.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.42.7 125.0%   
Avg P/E ratio x22.1-29.3 -75.5%  
P/CF ratio (eoy) x16.9296.8 5.7%  
Price / Book Value ratio x3.03.7 82.0%  
Dividend payout %11.0-12.0 -91.4%   
Avg Mkt Cap Rs m514,277442,238 116.3%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77729,893 72.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652164,055 93.0%  
Other income Rs m2,3542,137 110.2%   
Total revenues Rs m155,006166,192 93.3%   
Gross profit Rs m34,4272,152 1,599.5%  
Depreciation Rs m7,13016,587 43.0%   
Interest Rs m1,2701,428 89.0%   
Profit before tax Rs m28,381-13,726 -206.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1171,372 373.1%   
Profit after tax Rs m23,264-15,097 -154.1%  
Gross profit margin %22.61.3 1,718.9%  
Effective tax rate %18.0-10.0 -180.4%   
Net profit margin %15.2-9.2 -165.6%  
BALANCE SHEET DATA
Current assets Rs m122,614124,577 98.4%   
Current liabilities Rs m78,39482,764 94.7%   
Net working cap to sales %29.025.5 113.7%  
Current ratio x1.61.5 103.9%  
Inventory Days Days9333 280.0%  
Debtors Days Days8095 84.2%  
Net fixed assets Rs m144,38291,938 157.0%   
Share capital Rs m1,024909 112.7%   
"Free" reserves Rs m168,972119,006 142.0%   
Net worth Rs m169,996119,915 141.8%   
Long term debt Rs m3,6211,419 255.3%   
Total assets Rs m266,996216,515 123.3%  
Interest coverage x23.3-8.6 -271.0%   
Debt to equity ratio x00 180.1%  
Sales to assets ratio x0.60.8 75.5%   
Return on assets %9.2-6.3 -145.5%  
Return on equity %13.7-12.6 -108.7%  
Return on capital %17.1-10.1 -168.5%  
Exports to sales %00-   
Imports to sales %14.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,869NA-   
Fx inflow Rs m63,06553,594 117.7%   
Fx outflow Rs m21,86938,143 57.3%   
Net fx Rs m41,19615,451 266.6%   
CASH FLOW
From Operations Rs m21,0413,673 572.8%  
From Investments Rs m11,54412,922 89.3%  
From Financial Activity Rs m-8,683-15,723 55.2%  
Net Cashflow Rs m23,729872 2,720.6%  

Share Holding

Indian Promoters % 75.0 46.8 160.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 15.5 41.4 37.5%  
FIIs % 2.6 13.8 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 52.9 47.3%  
Shareholders   408,231 378,011 108.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    SANOFI INDIA    


More on Cadila Healthcare vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Lupin Share Price Performance

Period Cadila Healthcare Lupin S&P BSE HEALTHCARE
1-Day 2.28% 0.13% 0.33%
1-Month -3.70% 5.05% 0.28%
1-Year -13.04% -19.95% -6.55%
3-Year CAGR 16.15% -2.71% 20.31%
5-Year CAGR -1.98% -2.85% 10.96%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Lupin the stake stands at 47.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at -12.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.